Pharmaceutical companies in the EU are dependent on a right SPC term – Every day counts

On 15 October 2014 two questions were referred to the CJEU on a preliminary ruling regarding a SPC regulation;

Is the date for the first Marketing Authorisation (MA) which is used to determine the SPC term for medicinal products determined according to Community law or under national law?
And if determined under Community law, is the relevant date for determining the SPC term the decision date of the MA or the date of notification?

Read the whole article here